Evidence map›Paper›PMID 30728259›Full record

ArticleJournal of virology2019

Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.

Cyrille Mathieu, Marion Ferren, Eric Jurgens, Claire Dumont, Ksenia Rybkina, Olivia Harder, Debora Stelitano, Silvia Madeddu, Giuseppina Sanna, Dayna Schwartz and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Clinical features, pathogenesis, pathology, neuroimaging, clinical course and outcome of measles inclusion-body encephalitis: a systematic review of published case reports and case series.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Unraveling the complexities of neurotropic virus infection and immune evasion.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antiviral activity of nitazoxanide againstJournal of virus eradication · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Cyrille MathieuCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA cyrille.mathieu@inserm.fr mp3509@cumc.columbia.edu.
Marion FerrenCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Eric JurgensCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Claire DumontCIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.
Ksenia RybkinaCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Olivia HarderDepartment of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
Debora StelitanoCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Silvia MadedduCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Giuseppina SannaCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Dayna SchwartzCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Sudipta BiswasCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Diana HardieDivision of Medical Virology, Department of Clinical Laboratory Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, South Africa.
Takao HashiguchiDepartment of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Anne MosconaCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Branka HorvatCIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.ORCID 0000-0003-0578-7765
Stefan NiewieskDepartment of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
Matteo PorottoCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA cyrille.mathieu@inserm.fr mp3509@cumc.columbia.edu.
Columbia University Irving Medical Center · USUniversité Claude Bernard Lyon 1 · FRThe Ohio State University · USUniversity of Cagliari · ITKyushu University · JPNational Health Laboratory Service · ZAUniversity of Campania "Luigi Vanvitelli" · IT

Funding

Development of novel endosome-targeted Ebola virus entry inhibitors as antiviral agentsR01AI121349 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI POROTTO, MATTEO · 2016 to 2020
$3.2M
Mechanisms of measles virus CNS adaptationR01NS091263 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI POROTTO, MATTEO · 2015 to 2019
$1.9M
Development of therapeutic fusion inhibitor peptides for Measles encephalitisR01NS105699 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI POROTTO, MATTEO · 2018 to 2022
$1.8M
NIAID NIH HHS R01 AI121349NINDS NIH HHS R01 NS091263NINDS NIH HHS R01 NS105699
6 · The paper itself

Abstract

A clinical isolate of measles virus (MeV) bearing a single amino acid alteration in the viral fusion protein (F; L454W) was previously identified in two patients with lethal sequelae of MeV central nervous system (CNS) infection. The mutation dysregulated the viral fusion machinery so that the mutated F protein mediated cell fusion in the absence of known MeV cellular receptors. While this virus could feasibly have arisen via intrahost evolution of the wild-type (wt) virus, it was recently shown that the same mutation emerged under the selective pressure of small-molecule antiviral treatment. Under these conditions, a potentially neuropathogenic variant emerged outside the CNS. While CNS adaptation of MeV was thought to generate viruses that are less fit for interhost spread, we show that two animal models can be readily infected with CNS-adapted MeV via the respiratory route. Despite bearing a fusion protein that is less stable at 37°C than the wt MeV F, this virus infects and replicates in cotton rat lung tissue more efficiently than the wt virus and is lethal in a suckling mouse model of MeV encephalitis even with a lower inoculum. Thus, either during lethal MeV CNS infection or during antiviral treatment

Indexed as

Encephalitis, ViralInclusion Bodies, ViralMeaslesMutation, MissenseViral Fusion ProteinsVirus ReplicationAmino Acid SubstitutionAnimalsCentral Nervous SystemChlorocebus aethiopsDisease Models, AnimalHumansLungMeasles virusMiceMice, TransgenicViral Fusion Proteinscentral nervous system infectionsin vivo infectionpathogenesisviral fusion

Identifiers

PMID30728259
PMCPMC6450100
OpenAlexW2912590058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.